• Nemolizumab shows high success rates in prurigo nodularis

    Nemolizumab achieved the 2 primary endpoints in the phase 3 OLYMPIA 1 study for itch and Investigator’s Global Assessment success in prurigo nodularis.

  • Anti-IL17 blockade leads to maintained pain reduction in patients with HS

    A pooled analysis found that secukinumab treatment entailed a numerically greater pain reduction than placebo in patients with hidradenitis suppurativa.

  • Botanical drug solution improves AA hair regrowth for children and adolescents

    Twice-daily treatment with a plant extracts solution led to sustained hair regrowth in children and adolescents with alopecia areata in the phase 2/3 RAAINBOW trial.

  • Topical tapinarof: a rising star in atopic dermatitis

    Phase 3 results show its potential as a new agent for atopic dermatitis from early age. Over 45% of participants met the primary endpoint of clear or almost clear skin.

  • Update AMD: First drug approved for the treatment of geographic atrophy

    Over 5 million people globally suffer geographic atrophy linked to age-related macular degeneration. A new intravitreal drug was approved for its treatment.

  • Under the skin: tattoos and their consequences

    Tattoos are becoming increasingly popular, but these permanent body ornaments can cause considerable damage to the skin.

  • Proton-pump inhibitors and cancer therapy: a bad combination?

    Some retrospective studies suggested that combination of PPIs with immuno-chemotherapies, is associated with worse outcomes. What's new on this issue?

  • Medical Case: A patient with upper abdominal pain, nausea and fainting

    A 47-year-old female patient complains of an episode of fainting and unwanted weight loss, in addition to gastrointestinal issues. Could you guess a diagnosis?

  • When painful muscle cramps occur during sport: how to treat them?

    Athletes often treat cramps themselves, but the effectiveness of untargeted therapy is questionable. What helps with painful attacks and what doesn't?

  • How periodontal disease contributes to inflammation and rheumatoid arthritis

    Periodontal diseases enable oral mucosa tears, where citrullinated bacteria enter the bloodstream, leading to inflammatory immune cells and ACPA antibodies.

  • Options for augmentation in treatment-resistant age-related depression

    A substantial proportion geriatric patients taking antidepressants do not respond to therapy. Should they switch completely, just augment, and how?

  • A day at the ER: How many diagnoses can AI correctly make?

    ChatGPT could solve many questions on a medical exam, but using it on real people would quickly prove fatal, says a doctor who has put it to the test.

  • NET: What gastroenterologists should know

    Even gastroenterologists may struggle with this very special and heterogeneous group of neoplasms. But a correct diagnosis is usually within their grasp.

  • Psychedelics in psychiatry: yesterday, today, and tomorrow?

    In psychiatric therapy research, psychedelic-assisted psychotherapy is currently one of the most exciting areas of research. What trends could await us?

  • Psychedelic Augmented Psychotherapy: Science vs. Expectation

    Some patients seek psychedelic-augmented psychotherapy with quite high expectations. How should therapists approach this?

  • Obesity: can a healthy gut microbiome contribute to treatment?

    If the intestinal microbiome is unbalanced, chronic diseases or micro-inflammations often ensue. What role does intestinal flora dysfunction play in grade III obesity?

  • Medical Case: Patient with diarrhoea and lower abdominal pain

    A 20-year-old woman arrives to the emergency room with lower abdominal pain and changes in bowel movements. What is your probable diagnosis?

  • Dr Prateep Beed on psychedelics research, and its expanding contribution to medicine

    In this interview, Dr. Beed's global snapshot of today's psychedelics research covers therapeutics, policies, patient-doctor relations, and medical specialties.

  • Surgery for gastrointestinal tumours: Could AI take over soon?

    Artificial intelligence has also arrived in the operating room. Will it replace surgeons in the future?

  • Icons, gurus, and boundaries: Professional risks in psychedelic therapy settings

    Prof. Dr. Matthew Johnson looks at the challenges posed to psychedelics science professionals by patients' experiences and experimental settings.

  • 10 |
  • 11 |
  • 12 |
  • 13 |
  • 14 |
  • 15 |
  • 16 |
  • 17 |
  • 18 |
  • 19 |
  • 20 |